| US 7,495,103 B2 | ||
| Modulators of ATP-binding cassette transporters | ||
| Sara Hadida-Ruah, La Jolla, Calif. (US); Anna Hazelwood, San Diego, Calif. (US); Peter Grootenhuis, San Diego, Calif. (US); Fred Van Goor, San Diego, Calif. (US); Ashvani Singh, San Diego, Calif. (US); Jinglan Zhou, San Diego, Calif. (US); and Jason McCartney, Cardiff-by-the-Sea, Calif. (US) | ||
| Assigned to Vertex Pharmaceuticals Incorporated, Cambridge, Mass. (US) | ||
| Filed on Jun. 24, 2005, as Appl. No. 11/165,818. | ||
| Claims priority of provisional application 60/582676, filed on Jun. 24, 2004. | ||
| Claims priority of provisional application 60/630127, filed on Nov. 22, 2004. | ||
| Claims priority of provisional application 60/635674, filed on Dec. 13, 2004. | ||
| Claims priority of provisional application 60/658219, filed on Mar. 03, 2005. | ||
| Claims priority of provisional application 60/661311, filed on Mar. 11, 2005. | ||
| Prior Publication US 2006/0074075 A1, Apr. 06, 2006 | ||
| Int. Cl. C07D 215/38 (2006.01); A61K 31/44 (2006.01) | ||
| U.S. Cl. 546—156 [514/312] | 2 Claims |
| 1. A compound:
N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide, or a pharmaceutically acceptable salt thereof.
|